CLRB — CELLECTAR BIOSCIENCES INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
About CELLECTAR BIOSCIENCES INC (CLRB)
CELLECTAR BIOSCIENCES INC (CLRB) appears in the most recent 13F filings of 1 tracked institutional investor. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $103,746. All data sourced from SEC 13F filings.
Based on recent institutional activity in CLRB
No recent activity recorded.
How many top investors track CLRB
Only 1 tracked investor report this position.
CLRB Ownership Composition
How CELLECTAR BIOSCIENCES INC is held across tracked investor types, based on reported 13F positions.
- Other100.0%
Tracked investors reporting CLRB
- Ken GriffinSep 30, 2025Citadel AdvisorsShares18.5KValue$103.7K% Portfolio0.00%
Recent activity
- No recent activity.
Frequently asked questions
- How many institutional investors hold CLRB?
- 1 tracked institutional investor disclosed a position in CLRB (CELLECTAR BIOSCIENCES INC) in their most recent 13F filing.
- Who is the largest institutional holder of CLRB?
- Ken Griffin, Citadel Advisors, holds the largest disclosed position in CLRB, valued at $103,746.
- Did institutional ownership of CLRB increase or decrease?
- Across recent 13F filings, tracked investors recorded 0 new positions, 0 increased, 0 reduced, and 0 fully exited CLRB.
- Where does this CLRB ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.